Pharmacological activation of PKM2 by a small-molecule PKM2 activator, TEPP-46, rescued the metabolic and functional outcomes of I/R in Mtx2 deficiency mice. This evidence concerns the gene MTX2 and hyperinsulinemic hypoglycemia, familial, 4.